Novel Strategies for Natural Products Synthesis
$308,726R01FY2018GMNIH
University Of California Berkeley, Berkeley CA
Investigators
Linked publications & trials
Paper 29889509Paper 28858498Paper 28820600Paper 27525345Paper 26675722Paper 26028789Paper 25044869Paper 24249921Paper 24009078Paper 23533012Paper 23344433Paper 23061536Paper 22856329Paper 22593605Paper 22472049Paper 22214219Paper 22072189Paper 21572597Paper 20704267Paper 20672014Paper 20161322Paper 19902905Paper 19527042Paper 19222082Paper 17845052Paper 17451249Paper 17309277Paper 16354081Paper 16144376
Abstract
Abstract The goal of this program is to develop new strategies for the synthesis of diterpenoid alkaloid natural products. These compounds and their unique derivatives, which can only be accessed using our approach, will provide small molecules that will serve as novel small molecules to combat pain by modulating voltage-gated sodium ion channels. Our synthetic studies should also lead to new variants of [4+2] cycloadditions to achieve regioselectivity and enantioselectivity. Specifically, we intend to develop strategies to synthesize different structural classes of diterpenoid alkaloids including the aconitine- type, the arcutine type and the hetisine type.
View original record on NIH RePORTER →